These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628 [TBL] [Abstract][Full Text] [Related]
4. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological approach to diabetic retinopathy. De La Cruz JP; González-Correa JA; Guerrero A; de la Cuesta FS Diabetes Metab Res Rev; 2004; 20(2):91-113. PubMed ID: 15037985 [TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. Gilbert RE; Vranes D; Berka JL; Kelly DJ; Cox A; Wu LL; Stacker SA; Cooper ME Lab Invest; 1998 Aug; 78(8):1017-27. PubMed ID: 9714188 [TBL] [Abstract][Full Text] [Related]
7. Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey. Witmer AN; Blaauwgeers HG; Weich HA; Alitalo K; Vrensen GF; Schlingemann RO Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):849-57. PubMed ID: 11867607 [TBL] [Abstract][Full Text] [Related]
8. [Importance of mathematical analysis of the retinal image in diabetic retinopathy]. Kolár P; Starha P; Hájek D; Vlková E; Druckmüller M Cesk Slov Oftalmol; 2003 Jun; 59(3):160-70. PubMed ID: 12898718 [TBL] [Abstract][Full Text] [Related]
9. [Preretinal membranes in proliferative diabetic retinopathy. Permeability and ultrastructure]. Lai S; Rossi P; Rathschuler F; Bertagno R; Vittone P; Ciurlo G Ophtalmologie; 1988; 2(2):105-6. PubMed ID: 3247142 [No Abstract] [Full Text] [Related]
10. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy. Hogeboom van Buggenum IM; Polak BC; Reichert-Thoen JW; de Vries-Knoppert WA; van Hinsbergh VW; Tangelder GJ Diabetologia; 2002 Feb; 45(2):203-9. PubMed ID: 11935151 [TBL] [Abstract][Full Text] [Related]
11. Clinical factors related to the aqueous levels of vascular endothelial growth factor and hepatocyte growth factor in proliferative diabetic retinopathy. Shinoda K; Ishida S; Kawashima S; Wakabayashi T; Uchita M; Matsuzaki T; Takayama M; Shinmura K; Yamada M Curr Eye Res; 2000 Aug; 21(2):655-61. PubMed ID: 11148602 [TBL] [Abstract][Full Text] [Related]
12. High vitreous concentration of vascular endothelial growth factor in diabetic patients with proliferative retinopathy using statins. Liinamaa MJ; Savolainen MJ Ann Med; 2008; 40(3):209-14. PubMed ID: 18382886 [TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212 [TBL] [Abstract][Full Text] [Related]